Toluidine blue histology of cMSC constructs for initial chondrogenic screening. by Melissa A. MacIver (12850566)

Subjects:

Immunofluorescence of select extracellular matrix (ECM) components. by Melissa A. MacIver (12850566)

Subjects:

Characterization of passage 1 (P1) bone marrow-derived canine mesenchymal stromal cells (cMSCs). by Melissa A. MacIver (12850566)

Subjects:

TUNEL staining. by Melissa A. MacIver (12850566)

Subjects:

Safranin O and toluidine blue histology. by Melissa A. MacIver (12850566)

Subjects:

Experimental outline. by Melissa A. MacIver (12850566)

Subjects:

Cytotoxicity and total glycosaminoglycan (GAG) content. by Melissa A. MacIver (12850566)

Subjects:

Gross photography and construct weight for initial chondrogenic screening. by Melissa A. MacIver (12850566)

Subjects:

Inverse of time of appearance of hydrodynamic instability as a function of initial concentration <i>C</i>_h (<i>C</i>_l = 10⁻⁵ mol/l) for configurati... by Sławomir Grzegorczyn (12035398)

Differences of pain intensity (ΔVAS) during social isolation or quarantine (VAS_I) and previous to social isolation or quarantine (VAS_P). by Roxana Schwab (11331239)

Effects of chronic treatment with compound-326 on PD markers and gene expression in WAT in DIO mice. by Hiroaki Yashiro (2231686)

Effects of chronic treatment with compound-326 on plasma glucose and insulin during an OGTT, and HOMA-IR in DIO mice. by Hiroaki Yashiro (2231686)

Effects of chronic treatment with compound-326 on BW, calorie intake, and fat mass in DIO mice. by Hiroaki Yashiro (2231686)

Effects of chronic treatment with compound-326 on BW, calorie intake, and blood PD markers in DIO mice. by Hiroaki Yashiro (2231686)

Schematic representation of the effects of stepwise bromination of the benzene ring of benzotriazole (Bt), including interdependence of the molecular volume (A) and pK_a (B) of the products with their IC₅₀ for inhibition of protein kinase CK2α: (a) Green arrows follow sequential bromination of the central vicinal C(5)/C(6) atoms, leading to a moderate decrease of pK_a and a large decrease in IC₅₀; (b) Red arrows illustrate the lesser effects of bromination of the peripheral C(4)/C(7) atoms, resulting in a significant decrease of pK_a, with virtually no gain in inhibitory activity; (c) Black lines link products with the same number of bromine atoms, but substantially differing in pK_a and IC₅₀, culminating in the di- and tri-brominated derivatives with inhibitory activities comparable to that of TBBt. by Romualda Wąsik (119538)

Effect of protein size on the relationship between site-specific evolutionary rates and distance to the nearest catalytic residue. by Benjamin R. Jack (2637040)

“…The addition of distance to a structural-constraints (RSA and WCN) model increases the accuracy of rate prediction near the active site up to shell 3 (17.5 Å) in small proteins and up to shell 5 (27.5 Å) in large proteins. …”

Table_5_Toll-Like Receptor 2 Modulates Pulmonary Inflammation and TNF-α Release Mediated by Mycoplasma pneumoniae.xlsx by Ming Chen (115604)

Discovery of Novel <i>N</i>‑Hydroxy-1,2,4-oxadiazole-5-formamides as ASM Direct Inhibitors for the Treatment of Atherosclerosis by Kan Yang (49193)

Discovery of Novel <i>N</i>‑Hydroxy-1,2,4-oxadiazole-5-formamides as ASM Direct Inhibitors for the Treatment of Atherosclerosis by Kan Yang (49193)

Discovery of Novel <i>N</i>‑Hydroxy-1,2,4-oxadiazole-5-formamides as ASM Direct Inhibitors for the Treatment of Atherosclerosis by Kan Yang (49193)